吴一龙, 陆舜, 周清华, 张力, 程颖, 王洁, 汪步海, 胡成平, 林丽珠, 钟文昭, 宋勇, 杨农, 董晓荣, 赵健, 杨海虹, 郭卉, 闫小龙, 刘宏旭, 马锐, 林劼, 刘思旸, 陈椿, 王立峰, 周承志, 周明, 吴芳, 杨学宁, 杜瀛瀛, 姚煜, 邵阳, 洪少东, 崔久嵬, 全雪萍, 陈蓉蓉, 吴佳妍, 张嘉涛, 周建娅, 汪斌超, 程超, 王慧娟, 柳菁菁, 邬麟, 黄岩, 匡煜坤, 张永昌, 胡洁, 杨衿记, 冯卫能, 苏文媚, 范云, 杨帆, 陈明, 唐可京, 潘燚, 申鹏, 刘安文, 张海波, 梁文华, 周清, 马智勇, 蔡修宇, 刘慧, 陈龙飞, 揣少坤, 单建贞, 郑燕芳, 尤长宣, 朱晓霞, 李力, 张同梅, 涂海燕, 林武荣, 张绪超, 周鹏辉, 柯尊富, 梁会营, 中国抗癌协会肺癌专业委员会, 广东省临床试验协会/中国胸部肿瘤研究协作组. Ⅲ期非小细胞肺癌的处理: 共识与争鸣[J]. 循证医学, 2022, 22(3): 129-136. DOI: 10.12019/j.issn.1671-5144.2022.03.001
    引用本文: 吴一龙, 陆舜, 周清华, 张力, 程颖, 王洁, 汪步海, 胡成平, 林丽珠, 钟文昭, 宋勇, 杨农, 董晓荣, 赵健, 杨海虹, 郭卉, 闫小龙, 刘宏旭, 马锐, 林劼, 刘思旸, 陈椿, 王立峰, 周承志, 周明, 吴芳, 杨学宁, 杜瀛瀛, 姚煜, 邵阳, 洪少东, 崔久嵬, 全雪萍, 陈蓉蓉, 吴佳妍, 张嘉涛, 周建娅, 汪斌超, 程超, 王慧娟, 柳菁菁, 邬麟, 黄岩, 匡煜坤, 张永昌, 胡洁, 杨衿记, 冯卫能, 苏文媚, 范云, 杨帆, 陈明, 唐可京, 潘燚, 申鹏, 刘安文, 张海波, 梁文华, 周清, 马智勇, 蔡修宇, 刘慧, 陈龙飞, 揣少坤, 单建贞, 郑燕芳, 尤长宣, 朱晓霞, 李力, 张同梅, 涂海燕, 林武荣, 张绪超, 周鹏辉, 柯尊富, 梁会营, 中国抗癌协会肺癌专业委员会, 广东省临床试验协会/中国胸部肿瘤研究协作组. Ⅲ期非小细胞肺癌的处理: 共识与争鸣[J]. 循证医学, 2022, 22(3): 129-136. DOI: 10.12019/j.issn.1671-5144.2022.03.001
    WU Yi-long, LU Shun, ZHOU Qing-hua, ZHANG Li, CHENG Ying, WANG Jie, WANG Bu-hai, HU Cheng-ping, LIN Li-zhu, ZHONG Wen-zhao, SONG Yong, YANG Nong, DONG Xiao-rong, ZHAO Jian, YANG Hai-hong, GUO Hui, YAN Xiao-long, LIU Hong-xu, MA Rui, LIN Jie, LIU Si-yang, CHEN Chun, WANG Li-feng, ZHOU Cheng-zhi, ZHOU Ming, WU Fang, YANG Xue-ning, DU Ying-ying, YAO Yu, SHAO Yang, HONG Shao-dong, CUI Jiu-wei, QUAN Xue-ping, CHEN Rong-rong, WU Jia-yan, ZHANG Jia-tao, ZHOU Jian-ya, WANG Bin-chao, CHENG Chao, WANG Hui-juan, LIU Jing-jing, WU Lin, HUANG Yan, KUANG Yu-kun, ZHANG Yong-chang, HU Jie, YANG Jin-ji, FENG Wei-neng, SU Wen-mei, FAN Yun, YANG Fan, CHEN Ming, TANG Ke-jing, PAN Yi, SHEN Peng, LIU An-wen, ZHANG Hai-bo, LIANG Wen-hua, ZHOU Qing, MA Zhi-yong, CAI Xiu-yu, LIU Hui, CHEN Long-fei, CHUAI Shao-kun, SHAN Jian-zhen, ZHENG Yan-fang, YOU Chang-xuan, ZHU Xiao-xia, LI Li, ZHANG Tong-mei, TU Hai-yan, LIN Wu-rong, ZHANG Xu-chao, ZHOU Peng-hui, KE Zun-fu, LIANG Hui-ying, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials (GACT) / Chinese Thoracic Oncology Group(C-TONG). Management of Stage Ⅲ Non-Small Cell Lung Cancer: Consensus and Contention[J]. Journal of Evidence-Based Medicine, 2022, 22(3): 129-136. DOI: 10.12019/j.issn.1671-5144.2022.03.001
    Citation: WU Yi-long, LU Shun, ZHOU Qing-hua, ZHANG Li, CHENG Ying, WANG Jie, WANG Bu-hai, HU Cheng-ping, LIN Li-zhu, ZHONG Wen-zhao, SONG Yong, YANG Nong, DONG Xiao-rong, ZHAO Jian, YANG Hai-hong, GUO Hui, YAN Xiao-long, LIU Hong-xu, MA Rui, LIN Jie, LIU Si-yang, CHEN Chun, WANG Li-feng, ZHOU Cheng-zhi, ZHOU Ming, WU Fang, YANG Xue-ning, DU Ying-ying, YAO Yu, SHAO Yang, HONG Shao-dong, CUI Jiu-wei, QUAN Xue-ping, CHEN Rong-rong, WU Jia-yan, ZHANG Jia-tao, ZHOU Jian-ya, WANG Bin-chao, CHENG Chao, WANG Hui-juan, LIU Jing-jing, WU Lin, HUANG Yan, KUANG Yu-kun, ZHANG Yong-chang, HU Jie, YANG Jin-ji, FENG Wei-neng, SU Wen-mei, FAN Yun, YANG Fan, CHEN Ming, TANG Ke-jing, PAN Yi, SHEN Peng, LIU An-wen, ZHANG Hai-bo, LIANG Wen-hua, ZHOU Qing, MA Zhi-yong, CAI Xiu-yu, LIU Hui, CHEN Long-fei, CHUAI Shao-kun, SHAN Jian-zhen, ZHENG Yan-fang, YOU Chang-xuan, ZHU Xiao-xia, LI Li, ZHANG Tong-mei, TU Hai-yan, LIN Wu-rong, ZHANG Xu-chao, ZHOU Peng-hui, KE Zun-fu, LIANG Hui-ying, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials (GACT) / Chinese Thoracic Oncology Group(C-TONG). Management of Stage Ⅲ Non-Small Cell Lung Cancer: Consensus and Contention[J]. Journal of Evidence-Based Medicine, 2022, 22(3): 129-136. DOI: 10.12019/j.issn.1671-5144.2022.03.001

    /

    返回文章
    返回